Subscribe to RSS
Evaluation of CBC Parameters in Relation to PCR Test Results in Diagnosing Pediatric COVID-19 DiseaseFunding None.
Objective This study aimed to investigate whether complete blood count parameters have predictive properties in diagnosing coronavirus disease 2019 (COVID-19) in regard to positive polymerase chain reaction (PCR) test in children with a prediagnosis of COVID-19, and whether these parameters are related to the severity of clinical findings in children with COVID-19.
Methods This retrospective cross-sectional study included children who were hospitalized with a possible diagnosis of COVID-19 and had undergone PCR testing in the COVID-19 children's clinic. Probable case definition was made according to the COVID-19 diagnostic and therapeutic guidelines of the Ministry of Health of the Republic of Turkey.
Results A total of 133 patients were included in the study, of which 46 (34.6%) were negative for the PCR test and 87 (65.4%) were positive for the PCR test. white blood cell (WBC), neutrophil, lymphocyte, and platelet levels were significantly lower in the PCR positive group than in the PCR negative group. The platelet to mean platelet volume ratio (PLT/MPV) was significantly lower in the PCR positive group than the PCR negative group, whereas the platelet distribution width (PDW) of the PCR positive patient group was significantly higher than the PCR negative group. For the multivariable model with PDW and neutrophil to lymphocyte ratio/age factors included, F1 score was 0.864, area under the receiver operating characteristics was 0.804, and area under the precision-recall curve was 0.873. The decision tree had a 72.9% cross-validation accuracy value.
Conclusion WBC, neutrophils, lymphocytes, platelets, PLT/MPV, and PDW parameters could be used in conjunction with clinical symptoms and findings to predict the PCR test result.
KeywordsCOVID-19 - complete blood count - polymerase chain - platelet to mean platelet volume ratio - platelet distribution width
Received: 15 October 2020
Accepted: 24 June 2021
Article published online:
17 August 2021
© 2021. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
- 1 WHO. Coronavirus disease 2019 (COVID-19): situation report, 72. Accessed August 13, 2020 at: https://apps.who.int/iris/bitstream/handle/10665/331685/nCoVsitrep01Apr2020-eng.pdf
- 2 Sari YanartasM, Hancerli TorunS. COVID-19 and Child. Sağlık Bilimlerinde İleri Araştırmalar Dergisi 2020; 3 (Suppl. 01) 40-48
- 3 Dong Y, Mo XI, Hu Y. et al. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics 2020; 16: 16 DOI: 10.1542/peds.2020-0702.
- 4 Henry BM, Lippi G, Plebani M. Laboratory abnormalities in children with novel coronavirus disease 2019. Clin Chem Lab Med 2020; 58 (07) 1135-1138
- 5 Wang XF, Yuan J, Zheng YJ. et al. [Retracted: clinical and epidemiological characteristics of 34 children with 2019 novel coronavirus infection in Shenzhen]. Zhonghua Er Ke Za Zhi 2020; 58 (00) E008
- 6 Stojkovic Lalosevic M, Pavlovic Markovic A, Stankovic S. et al. Combined diagnostic efficacy of neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and mean platelet volume (MPV) as biomarkers of systemic inflammation in the diagnosis of colorectal cancer. Dis Markers 2019; 2019: 6036979
- 7 Han SY, Lee IR, Park SJ, Kim JH, Shin JI. Usefulness of neutrophil-lymphocyte ratio in young children with febrile urinary tract infection. Korean J Pediatr 2016; 59 (03) 139-144
- 8 Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: a link between thrombosis and inflammation?. Curr Pharm Des 2011; 17 (01) 47-58
- 9 Golwala ZM, Shah H, Gupta N, Sreenivas V, Puliyel JM. Mean platelet volume (MPV), platelet distribution width (PDW), platelet count and plateletcrit (PCT) as predictors of in-hospital paediatric mortality: a case-control study. Afr Health Sci 2016; 16 (02) 356-362
- 10 Yang AP, Liu JP, Tao WQ, Li HM. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol 2020; 84: 106504
- 11 Kerboua KE. NLR: A Cost-effective Nomogram to Guide Therapeutic Interventions in COVID-19. Immunol Invest 2021; 50 (01) 92-100
- 12 Tiwari N, Nath D, Madan J, Bajpai P, Madan U, Singh S. Novel insights into the hematological parameter abnormalities in pediatric COVID-19 cases: observation from a preliminary study of 11 pediatric COVID-19 cases in a tertiary care center of North India. Saudi J Pathol Microbiol 2020; 5 (05) 276-28
- 13 CDC. Coronavirus Disease 2019 (COVID-19) 2020 Interim Case Definition, Approved April 5, 2020. Accessed July 15, 2020 at: https://wwwn.cdc.gov/nndss/conditions/coronavirus-disease-2019-covid-19/case-definition/2020/
- 14 Chen ZM, Fu JF, Shu Q. et al. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World J Pediatr 2020; 16 (03) 240-246
- 15 Özdemir Ö, Pala A. Çocuklarda COVID-19 Enfeksiyonunun Tanisi, Tedavisi ve Korunma Yolları. J Biotechinol & Strategic Health Res 2020; 4: 14-21
- 16 Gaunt ER, Hardie A, Claas EC, Simmonds P, Templeton KE. Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method. J Clin Microbiol 2010; 48 (08) 2940-2947
- 17 Tahamtan A. Ardebili. Real-time RT-PCR in COVID-19 detection: issues affecting the results. Expert Rev Mol Diagn 2020; 20 (05) 453-454
- 18 Xia W, Shao J, Guo Y, Peng X, Li Z, Hu D. Clinical and CT features in pediatric patients with COVID-19 infection: different points from adults. Pediatr Pulmonol 2020; 55 (05) 1169-1174
- 19 She J, Liu L, Liu W. COVID-19 epidemic: disease characteristics in children. J Med Virol 2020; 92 (07) 747-754
- 20 Lu X, Zhang L, Du H. et al; Chinese Pediatric Novel Coronavirus Study Team. SARS-CoV-2 infection in children. N Engl J Med 2020; 382 (17) 1663-1665
- 21 CDC COVID-19 Response Team. Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020. MMWR Morb Mortal Wkly Rep 2020; 69 (14) 422-426
- 22 Demirçelik Y, Kanık A. Çocuklarda Covid-19: epidemiyoloji ve klinik bulgular. Tepecik Eğit. ve Araşt. Hast. Dergisi 2020; 30 (Ek sayı): 58-62 DOI: 10.5222/terh.2020.60320.
- 23 Tekin R, Aktar F, Ayaz C. Comparison of Inflammatory Markers between Adult and Pediatric Brucellosis Patients. Open Forum Infect Dis 2017; 4 (01) 350-351
- 24 Erdoğan S, Oto A, Boşnak M. The relation between mean platelet volume and mortality in critical pediatric patients. Turk J Pediatr 2015; 57 (06) 605-610
- 25 Nam M, Son BH, Seo JE, Kim IR, Park CK, Kim HK. Improved diagnostic and prognostic power of combined delta neutrophil index and mean platelet volume in pediatric sepsis. Ann Clin Lab Sci 2018; 48 (02) 223-230
- 26 Tamelytė E, Vaicekauskienė G, Dagys A, Lapinskas T, Jankauskaitė L. Early blood biomarkers to improve sepsis/bacteremia diagnostics in pediatric emergency settings. Medicina (Kaunas) 2019; 55 (04) 99
- 27 Rad A, Cin S, Akar N. Pediatrik Yaş Grubunda Trombosit İndisleri. HJBC 2011; 39 (01) 83-86
- 28 Lagunas-Rangel FA. Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis. J Med Virol 2020; 92 (10) 1733-1734